Farmaforum 2024

26 Sept 2024 | Madrid, Spain

ServiceUpdated on 23 September 2024

Efficacy syngenic models

Cristina Degrassi

CEO at MTTlab srl

Trieste, Italy

About

Syngenic models entail the implantation of murine cancer cells into a mouse.  Xenograft tumor models are effective tools for assessing in vivo efficacy of candidate cancer drugs.

Syngeneic models can thus test the efficacy of immuno-oncology agents as single therapies, or in combination with other anti-cancer drugs.

Type

  • Development

Applies to

  • Pharmaceutical industry

Similar opportunities